---
figid: PMC9492373__ECAM2022-1149231.002
pmcid: PMC9492373
image_filename: ECAM2022-1149231.002.jpg
figure_link: /pmc/articles/PMC9492373/figure/fig2/
number: Figure 2
figure_title: ''
caption: 'Effects of ATL-III on H9c2 cell proliferation. (a) Results of H9c2 cells
  treated with different doses of ATL-III (15, 30, 60, 120, and 240 μmol/L) for 24,
  48, and 72 h. (b) Effects of appropriate dose of ATL-III on TM-induced H9c2 cells.
  Data were mean ± SD; ∗∗P < 0.01 versus control group; ##P < 0.01 versus model group.'
article_title: Atractylenolide III Attenuates Apoptosis in H9c2 Cells by Inhibiting
  Endoplasmic Reticulum Stress through the GRP78/PERK/CHOP Signaling Pathway.
citation: Meng-yu Zuo, et al. Evid Based Complement Alternat Med. 2022;2022:1149231.
year: '2022'

doi: 10.1155/2022/1149231
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi

keywords:
---
